Global Cell And Gene Therapy Market Growth (Status And Outlook) 2021-2026

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Market Size 2016-2026
2.1.2 Cell and Gene Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Cell and Gene Therapy Segment by Type
2.2.1 Rare Diseases
2.2.2 Rare Diseases
2.2.3 Hematology
2.2.4 Cardiovascular
2.2.5 Ophthalmology
2.2.6 Neurology
2.2.7 Other Therapeutic Classes
2.3 Cell and Gene Therapy Market Size by Type
2.3.1 Global Cell and Gene Therapy Market Size CAGR by Type
2.3.2 Global Cell and Gene Therapy Market Size Market Share by Type (2016-2021)
2.4 Cell and Gene Therapy Segment by Application
2.4.1 Pharmaceutical and Biotechnology Companies
2.4.2 Research and Academic Institutions
2.4.3 Contract Research Organizations (CROs)
2.4.4 Hospital
2.4.5 Others
2.5 Cell and Gene Therapy Market Size by Application
2.5.1 Global Cell and Gene Therapy Market Size CAGR by Application
2.5.2 Global Cell and Gene Therapy Market Size Market Share by Application (2016-2021)

3 Cell and Gene Therapy Market Size by Players
3.1 Cell and Gene Therapy Market Size Market Share by Players
3.1.1 Global Cell and Gene Therapy Revenue by Players (2019-2021E)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Cell and Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Cell and Gene Therapy by Regions
4.1 Cell and Gene Therapy Market Size by Regions (2016-2021)
4.2 Americas Cell and Gene Therapy Market Size Growth (2016-2021)
4.3 APAC Cell and Gene Therapy Market Size Growth (2016-2021)
4.4 Europe Cell and Gene Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Cell and Gene Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Cell and Gene Therapy Market Size by Country (2016-2021)
5.2 Americas Cell and Gene Therapy Market Size by Type (2016-2021)
5.3 Americas Cell and Gene Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Cell and Gene Therapy Market Size by Region (2016-2021)
6.2 APAC Cell and Gene Therapy Market Size by Type (2016-2021)
6.3 APAC Cell and Gene Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Cell and Gene Therapy by Country (2016-2021)
7.2 Europe Cell and Gene Therapy Market Size by Type (2016-2021)
7.3 Europe Cell and Gene Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Cell and Gene Therapy by Region (2016-2021)
8.2 Middle East & Africa Cell and Gene Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Cell and Gene Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Cell and Gene Therapy Market Forecast
10.1 Global Cell and Gene Therapy Forecast by Regions (2021-2026)
10.1.1 Global Cell and Gene Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Cell and Gene Therapy Forecast
10.1.3 APAC Cell and Gene Therapy Forecast
10.1.4 Europe Cell and Gene Therapy Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Forecast
10.2 Americas Cell and Gene Therapy Forecast by Countries (2021-2026)
10.2.1 United States Cell and Gene Therapy Market Forecast
10.2.2 Canada Cell and Gene Therapy Market Forecast
10.2.3 Mexico Cell and Gene Therapy Market Forecast
10.2.4 Brazil Cell and Gene Therapy Market Forecast
10.3 APAC Cell and Gene Therapy Forecast by Region (2021-2026)
10.3.1 China Cell and Gene Therapy Market Forecast
10.3.2 Japan Cell and Gene Therapy Market Forecast
10.3.3 Korea Cell and Gene Therapy Market Forecast
10.3.4 Southeast Asia Cell and Gene Therapy Market Forecast
10.3.5 India Cell and Gene Therapy Market Forecast
10.3.6 Australia Cell and Gene Therapy Market Forecast
10.4 Europe Cell and Gene Therapy Forecast by Country (2021-2026)
10.4.1 Germany Cell and Gene Therapy Market Forecast
10.4.2 France Cell and Gene Therapy Market Forecast
10.4.3 UK Cell and Gene Therapy Market Forecast
10.4.4 Italy Cell and Gene Therapy Market Forecast
10.4.5 Russia Cell and Gene Therapy Market Forecast
10.5 Middle East & Africa Cell and Gene Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Cell and Gene Therapy Market Forecast
10.5.2 South Africa Cell and Gene Therapy Market Forecast
10.5.3 Israel Cell and Gene Therapy Market Forecast
10.5.4 Turkey Cell and Gene Therapy Market Forecast
10.5.5 GCC Countries Cell and Gene Therapy Market Forecast
10.6 Global Cell and Gene Therapy Forecast by Type (2021-2026)
10.8 Global Cell and Gene Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Information
11.1.2 Amgen Inc. Cell and Gene Therapy Product Offered
11.1.3 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Amgen Inc. Main Business Overview
11.1.5 Amgen Inc. Latest Developments
11.2 bluebird bio, Inc.
11.2.1 bluebird bio, Inc. Company Information
11.2.2 bluebird bio, Inc. Cell and Gene Therapy Product Offered
11.2.3 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 bluebird bio, Inc. Main Business Overview
11.2.5 bluebird bio, Inc. Latest Developments
11.3 Dendreon Pharmaceuticals LLC.
11.3.1 Dendreon Pharmaceuticals LLC. Company Information
11.3.2 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
11.3.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Dendreon Pharmaceuticals LLC. Main Business Overview
11.3.5 Dendreon Pharmaceuticals LLC. Latest Developments
11.4 Fibrocell Science, Inc.
11.4.1 Fibrocell Science, Inc. Company Information
11.4.2 Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
11.4.3 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Fibrocell Science, Inc. Main Business Overview
11.4.5 Fibrocell Science, Inc. Latest Developments
11.5 Human Stem Cells Institute
11.5.1 Human Stem Cells Institute Company Information
11.5.2 Human Stem Cells Institute Cell and Gene Therapy Product Offered
11.5.3 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Human Stem Cells Institute Main Business Overview
11.5.5 Human Stem Cells Institute Latest Developments
11.6 Kite Pharma, Inc.
11.6.1 Kite Pharma, Inc. Company Information
11.6.2 Kite Pharma, Inc. Cell and Gene Therapy Product Offered
11.6.3 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Kite Pharma, Inc. Main Business Overview
11.6.5 Kite Pharma, Inc. Latest Developments
11.7 Kolon TissueGene, Inc.
11.7.1 Kolon TissueGene, Inc. Company Information
11.7.2 Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
11.7.3 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Kolon TissueGene, Inc. Main Business Overview
11.7.5 Kolon TissueGene, Inc. Latest Developments
11.8 Novartis AG
11.8.1 Novartis AG Company Information
11.8.2 Novartis AG Cell and Gene Therapy Product Offered
11.8.3 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Novartis AG Main Business Overview
11.8.5 Novartis AG Latest Developments
11.9 Orchard Therapeutics plc.
11.9.1 Orchard Therapeutics plc. Company Information
11.9.2 Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
11.9.3 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Orchard Therapeutics plc. Main Business Overview
11.9.5 Orchard Therapeutics plc. Latest Developments
11.10 Organogenesis Holdings Inc.
11.10.1 Organogenesis Holdings Inc. Company Information
11.10.2 Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
11.10.3 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Organogenesis Holdings Inc. Main Business Overview
11.10.5 Organogenesis Holdings Inc. Latest Developments
11. Pfizer, Inc.
11.11.1 Pfizer, Inc. Company Information
11.11.2 Pfizer, Inc. Cell and Gene Therapy Product Offered
11.11.3 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Pfizer, Inc. Main Business Overview
11.11.5 Pfizer, Inc. Latest Developments
11.12 RENOVA THERAPEUTICS
11.12.1 RENOVA THERAPEUTICS Company Information
11.12.2 RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
11.12.3 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 RENOVA THERAPEUTICS Main Business Overview
11.12.5 RENOVA THERAPEUTICS Latest Developments
11.13 Shanghai Sunway Biotech Co., Ltd.,
11.13.1 Shanghai Sunway Biotech Co., Ltd., Company Information
11.13.2 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
11.13.3 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Shanghai Sunway Biotech Co., Ltd., Main Business Overview
11.13.5 Shanghai Sunway Biotech Co., Ltd., Latest Developments
11.14 Sibiono GeneTech Co. Ltd.,
11.14.1 Sibiono GeneTech Co. Ltd., Company Information
11.14.2 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
11.14.3 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Sibiono GeneTech Co. Ltd., Main Business Overview
11.14.5 Sibiono GeneTech Co. Ltd., Latest Developments
11.15 Spark Therapeutics, Inc.
11.15.1 Spark Therapeutics, Inc. Company Information
11.15.2 Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Spark Therapeutics, Inc. Main Business Overview
11.15.5 Spark Therapeutics, Inc. Latest Developments
11.16 Vericel Corporation
11.16.1 Vericel Corporation Company Information
11.16.2 Vericel Corporation Cell and Gene Therapy Product Offered
11.16.3 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Vericel Corporation Main Business Overview
11.16.5 Vericel Corporation Latest Developments
11.17 ViroMed Co., Ltd.
11.17.1 ViroMed Co., Ltd. Company Information
11.17.2 ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
11.17.3 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 ViroMed Co., Ltd. Main Business Overview
11.17.5 ViroMed Co., Ltd. Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Cell and Gene Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Rare Diseases
Table 3. Major Players of Oncology
Table 4. Major Players of Hematology
Table 5. Major Players of Cardiovascular
Table 6. Major Players of Ophthalmology
Table 7. Major Players of Neurology
Table 8. Major Players of Other Therapeutic Classes
Table 9. Cell and Gene Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 10. Global Cell and Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 11. Global Cell and Gene Therapy Market Size Market Share by Type (2016-2021)
Table 12. Cell and Gene Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 13. Global Cell and Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 14. Global Cell and Gene Therapy Market Size Market Share by Application (2016-2021)
Table 15. Global Cell and Gene Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 16. Global Cell and Gene Therapy Revenue Market Share by Players (2019-2021E)
Table 17. Cell and Gene Therapy Key Players Head office and Products Offered
Table 18. Cell and Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Cell and Gene Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 22. Global Cell and Gene Therapy Market Size Market Share by Regions 2016-2021
Table 23. Americas Cell and Gene Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 24. Americas Cell and Gene Therapy Market Size Market Share by Country (2016-2021)
Table 25. Americas Cell and Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 26. Americas Cell and Gene Therapy Market Size Market Share by Type (2016-2021)
Table 27. Americas Cell and Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 28. Americas Cell and Gene Therapy Market Size Market Share by Application (2016-2021)
Table 29. APAC Cell and Gene Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 30. APAC Cell and Gene Therapy Market Size Market Share by Region (2016-2021)
Table 31. APAC Cell and Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 32. APAC Cell and Gene Therapy Market Size Market Share by Type (2016-2021)
Table 33. APAC Cell and Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 34. APAC Cell and Gene Therapy Market Size Market Share by Application (2016-2021)
Table 35. Europe Cell and Gene Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 36. Europe Cell and Gene Therapy Market Size Market Share by Country (2016-2021)
Table 37. Europe Cell and Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 38. Europe Cell and Gene Therapy Market Size Market Share by Type (2016-2021)
Table 39. Europe Cell and Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 40. Europe Cell and Gene Therapy Market Size Market Share by Application (2016-2021)
Table 41. Middle East & Africa Cell and Gene Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region (2016-2021)
Table 43. Middle East & Africa Cell and Gene Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type (2016-2021)
Table 45. Middle East & Africa Cell and Gene Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 46. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application (2016-2021)
Table 47. Key and Potential Regions of Cell and Gene Therapy
Table 48. Key Application and Potential Industries of Cell and Gene Therapy
Table 49. Key Challenges of Cell and Gene Therapy
Table 50. Key Trends of Cell and Gene Therapy
Table 51. Global Cell and Gene Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 52. Global Cell and Gene Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 53. Global Cell and Gene Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 54. Global Cell and Gene Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 55. Global Cell and Gene Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 56. Global Cell and Gene Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 57. Amgen Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 58. Amgen Inc. Cell and Gene Therapy Product Offered
Table 59. Amgen Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 60. Amgen Inc. Main Business
Table 61. Amgen Inc. Latest Developments
Table 62. bluebird bio, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 63. bluebird bio, Inc. Cell and Gene Therapy Product Offered
Table 64. bluebird bio, Inc. Main Business
Table 65. bluebird bio, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. bluebird bio, Inc. Latest Developments
Table 67. Dendreon Pharmaceuticals LLC. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 68. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product Offered
Table 69. Dendreon Pharmaceuticals LLC. Main Business
Table 70. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. Dendreon Pharmaceuticals LLC. Latest Developments
Table 72. Fibrocell Science, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 73. Fibrocell Science, Inc. Cell and Gene Therapy Product Offered
Table 74. Fibrocell Science, Inc. Main Business
Table 75. Fibrocell Science, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Fibrocell Science, Inc. Latest Developments
Table 77. Human Stem Cells Institute Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 78. Human Stem Cells Institute Cell and Gene Therapy Product Offered
Table 79. Human Stem Cells Institute Main Business
Table 80. Human Stem Cells Institute Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Human Stem Cells Institute Latest Developments
Table 82. Kite Pharma, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 83. Kite Pharma, Inc. Cell and Gene Therapy Product Offered
Table 84. Kite Pharma, Inc. Main Business
Table 85. Kite Pharma, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. Kite Pharma, Inc. Latest Developments
Table 87. Kolon TissueGene, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 88. Kolon TissueGene, Inc. Cell and Gene Therapy Product Offered
Table 89. Kolon TissueGene, Inc. Main Business
Table 90. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. Kolon TissueGene, Inc. Latest Developments
Table 92. Novartis AG Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 93. Novartis AG Cell and Gene Therapy Product Offered
Table 94. Novartis AG Main Business
Table 95. Novartis AG Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Novartis AG Latest Developments
Table 97. Orchard Therapeutics plc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 98. Orchard Therapeutics plc. Cell and Gene Therapy Product Offered
Table 99. Orchard Therapeutics plc. Main Business
Table 100. Orchard Therapeutics plc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Orchard Therapeutics plc. Latest Developments
Table 102. Organogenesis Holdings Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 103. Organogenesis Holdings Inc. Cell and Gene Therapy Product Offered
Table 104. Organogenesis Holdings Inc. Main Business
Table 105. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 106. Organogenesis Holdings Inc. Latest Developments
Table 107. Pfizer, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 108. Pfizer, Inc. Cell and Gene Therapy Product Offered
Table 109. Pfizer, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 110. Pfizer, Inc. Main Business
Table 111. Pfizer, Inc. Latest Developments
Table 112. RENOVA THERAPEUTICS Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 113. RENOVA THERAPEUTICS Cell and Gene Therapy Product Offered
Table 114. RENOVA THERAPEUTICS Main Business
Table 115. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 116. RENOVA THERAPEUTICS Latest Developments
Table 117. Shanghai Sunway Biotech Co., Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 118. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product Offered
Table 119. Shanghai Sunway Biotech Co., Ltd., Main Business
Table 120. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 121. Shanghai Sunway Biotech Co., Ltd., Latest Developments
Table 122. Sibiono GeneTech Co. Ltd., Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 123. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product Offered
Table 124. Sibiono GeneTech Co. Ltd., Main Business
Table 125. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 126. Sibiono GeneTech Co. Ltd., Latest Developments
Table 127. Spark Therapeutics, Inc. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 128. Spark Therapeutics, Inc. Cell and Gene Therapy Product Offered
Table 129. Spark Therapeutics, Inc. Main Business
Table 130. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 131. Spark Therapeutics, Inc. Latest Developments
Table 132. Vericel Corporation Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 133. Vericel Corporation Cell and Gene Therapy Product Offered
Table 134. Vericel Corporation Main Business
Table 135. Vericel Corporation Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 136. Vericel Corporation Latest Developments
Table 137. ViroMed Co., Ltd. Details, Company Type, Cell and Gene Therapy Area Served and Its Competitors
Table 138. ViroMed Co., Ltd. Cell and Gene Therapy Product Offered
Table 139. ViroMed Co., Ltd. Main Business
Table 140. ViroMed Co., Ltd. Cell and Gene Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 141. ViroMed Co., Ltd. Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Cell and Gene Therapy Market Size Market Share by Type in 2020
Figure 7. Cell and Gene Therapy in Pharmaceutical and Biotechnology Companies
Figure 8. Global Cell and Gene Therapy Market: Pharmaceutical and Biotechnology Companies (2016-2021) & ($ Millions)
Figure 9. Cell and Gene Therapy in Research and Academic Institutions
Figure 10. Global Cell and Gene Therapy Market: Research and Academic Institutions (2016-2021) & ($ Millions)
Figure 11. Cell and Gene Therapy in Contract Research Organizations (CROs)
Figure 12. Global Cell and Gene Therapy Market: Contract Research Organizations (CROs) (2016-2021) & ($ Millions)
Figure 13. Cell and Gene Therapy in Hospital
Figure 14. Global Cell and Gene Therapy Market: Hospital (2016-2021) & ($ Millions)
Figure 15. Cell and Gene Therapy in Others
Figure 16. Global Cell and Gene Therapy Market: Others (2016-2021) & ($ Millions)
Figure 17. Global Cell and Gene Therapy Market Size Market Share by Application in 2020
Figure 18. Global Cell and Gene Therapy Revenue Market Share by Player in 2020
Figure 19. Global Cell and Gene Therapy Market Size Market Share by Regions (2016-2021)
Figure 20. Americas Cell and Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 21. APAC Cell and Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 22. Europe Cell and Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 23. Middle East & Africa Cell and Gene Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Americas Cell and Gene Therapy Market Size Market Share by Country in 2020
Figure 25. Americas Cell and Gene Therapy Market Size Market Share by Type in 2020
Figure 26. Americas Cell and Gene Therapy Market Size Market Share by Application in 2020
Figure 27. United States Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 28. Canada Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 29. Mexico Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. APAC Cell and Gene Therapy Market Size Market Share by Regions in 2020
Figure 31. APAC Cell and Gene Therapy Market Size Market Share by Type in 2020
Figure 32. APAC Cell and Gene Therapy Market Size Market Share by Application in 2020
Figure 33. China Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 34. Japan Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 35. Korea Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Southeast Asia Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. India Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Australia Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. Europe Cell and Gene Therapy Market Size Market Share by Country in 2020
Figure 40. Europe Cell and Gene Therapy Market Size Market Share by Type in 2020
Figure 41. Europe Cell and Gene Therapy Market Size Market Share by Application in 2020
Figure 42. Germany Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 43. France Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 44. UK Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. Italy Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. Russia Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Region in 2020
Figure 48. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Type in 2020
Figure 49. Middle East & Africa Cell and Gene Therapy Market Size Market Share by Application in 2020
Figure 50. Egypt Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 51. South Africa Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 52. Israel Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. Turkey Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. GCC Country Cell and Gene Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Americas Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 56. APAC Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 57. Europe Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 58. Middle East & Africa Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 59. United States Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Canada Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 61. Mexico Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Brazil Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 63. China Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Japan Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 65. Korea Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Southeast Asia Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 67. India Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Australia Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 69. Germany Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 70. France Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 71. UK Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 72. Italy Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 73. Russia Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Spain Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Egypt Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 76. South Africa Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Israel Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 78. Turkey Cell and Gene Therapy Market Size 2021-2026 ($ Millions)
Figure 79. GCC Country Cell and Gene Therapy Market Size 2021-2026 ($ Millions)

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.